# Jane L. Messina

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jane-l-messina/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,691 |
| Field | Cutaneous Melanoma Detection and Management |
| h-index | 68 |
| i10-index | 211 |
| Last Known Institution | Moffitt Cancer Center |
| OpenAlex ID | https://openalex.org/A5013677681 |
| ORCID iD | 0000-0002-0332-0224 |
| Works | 591 |

## Researcher papers

- [Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes](https://scholariq.org/papers/expression-of-indoleamine-2-3-dioxygenase-by-plasmacytoid-dendritic-cells-in/)
- [Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma](https://scholariq.org/papers/phase-i-trial-of-interleukin-12-plasmid-electroporation-in-patients-with/)
- [Guidelines of care for the management of cutaneous squamous cell carcinoma](https://scholariq.org/papers/guidelines-of-care-for-the-management-of-cutaneous-squamous-cell-carcinoma/)
- [PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression](https://scholariq.org/papers/pten-loss-confers-braf-inhibitor-resistance-to-melanoma-cells-through-the/)
- [Guidelines of care for the management of basal cell carcinoma](https://scholariq.org/papers/guidelines-of-care-for-the-management-of-basal-cell-carcinoma/)
- [12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?](https://scholariq.org/papers/12-chemokine-gene-signature-identifies-lymph-node-like-structures-in-melanoma/)
- [High response rate to PD-1 blockade in desmoplastic melanomas](https://scholariq.org/papers/high-response-rate-to-pd-1-blockade-in-desmoplastic-melanomas/)
- [Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/merkel-cell-carcinoma-version-1-2018-nccn-clinical-practice-guidelines-in/)
- [Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy](https://scholariq.org/papers/recovery-of-phospho-erk-activity-allows-melanoma-cells-to-escape-from-braf/)
- [Primary mucosal melanoma](https://scholariq.org/papers/primary-mucosal-melanoma/)
- [Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma](https://scholariq.org/papers/clinicopathologic-predictors-of-sentinel-lymph-node-metastasis-in-thin-melanoma/)
- [Cutaneous Reactions to Iron Infusions: A Case Report and Clinical Review](https://scholariq.org/papers/cutaneous-reactions-to-iron-infusions-a-case-report-and-clinical-review/)

## Researcher topics

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)

## Researcher university

- [Moffitt Cancer Center](https://scholariq.org/institutions/moffitt-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.